2151. High burden of AIDS defining conditions and increased mortality with hepatitis coinfection in HIV-infected adults in an inner city Medical Intensive Care Unit
Session: Poster Abstract Session: HIV/HCV Coinfection and Liver Disease
Saturday, October 29, 2016
Room: Poster Hall
Background: The burden of HIV infection remains high in some regions of the US, including Baltimore, and is often associated with poor uptake of antiretroviral therapy (ART). AIDS defining conditions (AIDS-DC) are frequent as is coinfection with hepatitis B or C (HBV/HCV). HCV coinfection may increase mortality, including in individuals admitted to the medical intensive care unit (MICU). Here we describe diagnoses and outcomes of HIV infected patients admitted to the MICU of a large tertiary care referral hospital and compare mortality in patients with and without hepatitis coinfection and ART use.

Methods: We performed a retrospective cohort study of 297 HIV+ patients with first admission to MICU for > 24 hours between 7/2009 and 7/2014. This preliminary analysis includes 113 patients, randomly selected. Data on discharge diagnoses, comorbid conditions, disease severity scores, CD4 cell counts, HIV viral load (VL), HBV/HCV serology, ART use and short- and long-term mortality were collected. The relationship between hepatitis coinfection, ART use, qualitative VL and mortality was analyzed (χ2test).

Results: Of 113 patients, 65% (N=73) were male, 83% (N=94) were African American, and the mean age was 44±12 years. 43 patients (38%) had >= one current AIDS-DC and 8 patients had two. The VL was detectable in 82% (median: 59,700 copies/ml, IQR 235,653) and the median CD4 was 64 cells/mm3 (IQR 173). 53% (N= 60) were not receiving ART while in the MICU, of which 68% (N=41) were not on ART before admission. 52 patients (46%) had positive hepatitis serology (positive anti-HCV and/or anti-HBc and/or HBsAg). MICU mortality was higher in patients with hepatitis coinfection versus HIV monoinfection: 28.9% vs 6.1%, (OR 6.28, 95%CI: 1.33, 29.62, p=0.0105). Significant mortality differences persisted with follow up to 180 days. There was no difference in outcome by ART use or qualitative VL.

Conclusion: Our data reveal a large burden of uncontrolled HIV infection and AIDS in this inner city population with poor ART utilization. Hepatitis coinfection is associated with increased mortality in univariate analysis. The study emphasizes the importance of improved HIV and hepatitis treatment and control. ICU physicians can still expect to diagnose and treat a wide range of AIDS-DC.

Eric Miller, MD1, Carl Nieweld, MD1, Michelle Doll, MD, MPH2, Kapil Saharia, MD, MPH3 and Ulrike Buchwald, MD, Dr. med3, (1)Department of Medicine, University of Maryland Medical Center, Baltimore, MD, (2)Division of Infectious Diseases, Virginia Commonwealth University Medical Center, Richmond, VA, (3)Institute of Human Virology and Division of Infectious Diseases, University of Maryland School of Medicine, Baltimore, MD

Disclosures:

E. Miller, None

C. Nieweld, None

M. Doll, None

K. Saharia, None

U. Buchwald, None

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.